Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001140361-25-004241·Adaptive Biotechnologies Corp
Schedule 13G ownership disclosure
ADAPTIVE BIOTECHNOLOGIES CORP
Common stock, par value $0.0001 per share · CUSIP: 00650F109
Event date: 2024-12-31
- Filing-level shares
- 6,833,137
- Percent of class
- 4.63%
- Nikko Asset Management Americas, Inc.
Shares: 6,833,137 · Class: 4.63%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-25-004241
- Form type
- SCHEDULE 13G/A
- Filer
- Adaptive Biotechnologies Corp
- CIK
- CIK 1478320
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership